Tag: Novo Holdings
Novo Nordisk announces $11bn acquisition of fill-finish sites to boost global manufacturing
In a strategic move to enhance its global manufacturing capabilities, Novo Nordisk has announced a significant acquisition from Novo Holdings A/S, involving three fill-finish sites, ... Read More
Hemab Therapeutics raises $135m for prophylactic treatments for bleeding and thrombotic disorders
Hemab Therapeutics, a clinical-stage biotechnology company, has raised $135 million in a Series B financing round for advancing prophylactic treatments for underserved bleeding and thrombotic ... Read More
Elo Life Systems secures $24.5m for natural, plant-based sweetener products
Elo Life Systems, a US-based food ingredient manufacturer, has raised $24.5 million, closing its Series A financing round, to accelerate the development of its natural, ... Read More
French biotech company Amolyt Pharma Series C round fetches $138m
Amolyt Pharma, a France-based clinical-stage biotechnology company, has secured €130 million (around $138 million) from a Series C equity financing round led by Sofinnova Partners ... Read More
AI drug discovery company Exscientia raises $60m in Series C round
Exscientia, a UK-based artificial intelligence (AI) drug discovery company, has secured $60 million in a Series C financing round led by new investor Novo Holdings, ... Read More